Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 15738539

Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2005 May 1
First author
Moreton P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2005 May 1;23(13):2884-5. doi: 10.1200/JCO.2005.11.932.
    note
    Source null
    related pmid
    15738532
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2005 Oct 1;23(28):7240-1; author reply 7241-2. doi: 10.1200/JCO.2005.02.5981.
    note
    Source null
    related pmid
    16192616
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2005 Nov 1;23(31):8122-3; author reply 8123-4. doi: 10.1200/JCO.2005.03.0148.
    note
    Source null
    related pmid
    16258114
    relationship
    Comment in

Authors and identifiers

  1. name
    Moreton P
    type
    Author
  2. name
    Kennedy B
    type
    Author
  3. name
    Lucas G
    type
    Author
  4. name
    Leach M
    type
    Author
  5. name
    Rassam SM
    type
    Author
  6. name
    Haynes A
    type
    Author
  7. name
    Tighe J
    type
    Author
  8. name
    Oscier D
    type
    Author
  9. name
    Fegan C
    type
    Author
  10. name
    Rawstron A
    type
    Author
  11. name
    Hillmen P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Moreton P
    type
    Author
  2. name
    Kennedy B
    type
    Author
  3. name
    Lucas G
    type
    Author
  4. name
    Leach M
    type
    Author
  5. name
    Rassam SM
    type
    Author
  6. name
    Haynes A
    type
    Author
  7. name
    Tighe J
    type
    Author
  8. name
    Oscier D
    type
    Author
  9. name
    Fegan C
    type
    Author
  10. name
    Rawstron A
    type
    Author
  11. name
    Hillmen P
    type
    Author
bibliography ids
  1. nci-bib-5ec194a26fb8412ffa3f5f64
book metadata
content sha256
06f9c32277301869007bf8094b766a78cb1ea5859f1f81d3fe2b5c9598759673
document type
citation
dois
  1. 10.1200/JCO.2005.04.021
electronic publication date
display
2005 Feb 28
precision
day
year
2005
evidence scope
bibliographic_metadata_only
id
pubmed:15738539
immutable id
pubmed:15738539@06f9c32277301869007bf8094b766a78cb1ea5859f1f81d3fe2b5c9598759673
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
13
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2971-9
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2005 May 1;23(13):2884-5. doi: 10.1200/JCO.2005.11.932.
    note
    Source null
    related pmid
    15738532
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2005 Oct 1;23(28):7240-1; author reply 7241-2. doi: 10.1200/JCO.2005.02.5981.
    note
    Source null
    related pmid
    16192616
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2005 Nov 1;23(31):8122-3; author reply 8123-4. doi: 10.1200/JCO.2005.03.0148.
    note
    Source null
    related pmid
    16258114
    relationship
    Comment in
outcomes validated
false
pmid
15738539
provenance
batch id
c1587c4840dc976b65de
provider
NCBI PubMed ESummary
record sha256
7997e9d60d4546da814e7260fdbfd2f7e17c2f814893292fa56c52fe745ebaac
response sha256
1dc03bdea4f6d08d05f92b6e458fb2ffa8a3c523f1f3e268fece6307fc70dead
retrieved at
2026-09-09T23:45:59.852120+00:00
publication date
display
2005 May 1
precision
day
year
2005
publication types
  1. Clinical Trial
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/15738539/
title
Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival.

Preserved source evidence · Not medical advice